Pressure BioSciences (OTCQB: PBIO), a leader in the
development and sale of broadly enabling, pressure-based instruments,
consumables and platform solutions, recently named Dr. Bradford A. Young as its
senior vice president and chief commercial officer. An article discussing the
company’s recent appointment reads, “Young joins the Pressure BioSciences
management team with a solid entrepreneurial background and the experience of
providing executive level consulting for strategic planning, product development
and commercialization to various biomedical, diagnostic and pharmaceutical
companies. In his new position as senior vice president and chief commercial
officer, he will play a critical role in advancing the company’s
commercialization programs and overall strategic planning, with a view toward
establishing new and/or enhanced revenue opportunities and significant
partnerships. … More specifically, Young will promote the company’s
instruments, consumables and technology platforms with synergistic companies worldwide,
with a goal of integrating Pressure BioSciences’ products into their offerings.
These types of collaborations and partnerships could result in major volume
sales, enabling the company to significantly boost its revenue.”
To view the full article, visit http://ibn.fm/mLTOf
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the
development and sale of innovative, broadly enabling, pressure-based solutions
for the worldwide life sciences industry. The company’s products are based on
the unique properties of both constant (i.e., static) and alternating (i.e.,
pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented
enabling technology platform that uses alternating cycles of hydrostatic
pressure between ambient and ultra-high levels to safely and reproducibly
control bio-molecular interactions (e.g., cell lysis, biomolecule extraction).
PBIO’s primary focus is in the development of PCT-based products for biomarker
and target discovery, drug design and development, biotherapeutics
characterization and quality control, soil & plant biology, forensics, and
counter-bioterror applications. Additionally, major new market opportunities
have emerged in the use of its pressure-based technologies in the following
areas: (1) the use of its recently acquired PreEMT technology from BaroFold,
Inc. to allow entry into the biologics contract research services sector, and
(2) the use of its recently-patented, scalable, high-efficiency, pressure-based
Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of
otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher
quality, homogenized, extended shelf-life or room temperature stable low-acid
liquid foods that cannot be effectively preserved using existing non-thermal
technologies. For more information, visit the company’s website at www.PressureBiosciences.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks
are designed to keep investors up to date on important and breaking news in the
small-cap and micro-cap markets. Spanning all industries, including energy,
entertainment, telecommunications, healthcare, retail and more, these news breaks
deliver opportunities the investment community may have missed. Whether it is
earnings results, mergers and acquisitions, or any other market-moving news,
our news breaks keep you in the know. QualityStocks is committed to connecting
subscribers with companies that have huge potential to succeed in the short and
long-term future. It is part of our mission statement to help the investment
community discover emerging companies that offer excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment